| Autor: |
Elounais, Farah, Aburahma, Ahmed, Alkotob, Mohammad Luay, Al Hadidi, Samer |
| Zdroj: |
BMJ Case Reports; 9/27/2017, Vol. 2017, p1-2, 2p, 2 Graphs |
| Abstrakt: |
Fingolimod, a sphingosine-1-phosphate receptor modulator, is used for the treatment of relapsingremitting multiple sclerosis. It is well known to cause bradyarrhythmias. We present a 63-year-old woman who was admitted to the hospital with sustained monomorphic ventricular tachycardia 2 weeks after fingolimod initiation. Further evaluation showed that the patient's ventricular tachycardia was most likely secondary to her medication. Medical practitioners need to be aware of such possible life-threatening side effects while using fingolimod. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
